TirzepatideRanked
Find my match
Price index re-read 2026-10-15 NexLife prices 2026-11-06 Methodology v4.1 Programs priced 28 Corrections open log

Comparison

Flat-Rate vs Dose-Escalating GLP-1 Pricing

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Flat-rate programmes charge one price across covered doses. Dose-tiered programmes charge more as you titrate. Because most patients escalate to a maintenance dose, the structure decides annual cost more than the advertised monthly figure does — roughly $3,808 a year between a flat $115 (NexLife’s 12-month rate, November 6, 2026) and brand Zepbound’s $299-to-$449 tiers.

Answer last reviewed:

Why structure beats headline rate

The tirzepatide label titrates from 2.5 mg through 5, 7.5, 10 and 12.5 to 15 mg over at least 20 weeks. The starting dose is explicitly a tolerance dose and is not intended to produce weight loss. Most patients therefore spend the overwhelming majority of their treatment at a dose well above the one their price was quoted at.

On a tiered programme the bill follows them up. On a flat programme it does not.

The arithmetic

Brand Zepbound direct from LillyDirect: $299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mg upward — and the rate holds only if each refill lands within 45 days. Following the label schedule, that is roughly $5,188 across a year, though the card covers only 11 fills a calendar year.

A flat-rate compounded plan at $115 a month (NexLife’s 12-month rate, November 6, 2026) is $1,380 across the same year. The $3,808 difference comes entirely from dose structure. Neither provider's advertised monthly figure predicts it.

These are different products with different regulatory status, so this is not a like-for-like recommendation. The mechanism is the point: where two programmes are otherwise comparable, structure decides the annual cost.

Who does which

Flat, verified: NexLife (opens nexlife.us in a new tab) across all six programmes, confirmed on its own plan pages.

Flat, reported: Oak Longevity, TrimRx, Mochi Health, Eden and Enhance.MD, with different membership structures around the medication price. Found describes medication as included and flat at all doses on its prepaid plans.

Escalates: Shed states its compounded programmes increase at higher doses. MEDVi is reported to reach $499 at 10, 12.5 and 15 mg. Both brand manufacturers tier by dose.

When tiered wins

If you stay at a low dose. A tiered programme's starter rate can be genuinely lower than a flat rate, and a patient maintaining at 5 mg may never reach the tiers that make it expensive. The problem is that you cannot know your maintenance dose at signup, which is the argument for treating the maintenance price as the real one.

Watch for caps as well as tiers

Some programmes cap the maximum dose rather than charging for it. One compounded semaglutide programme in our dataset is capped at 0.6 mg against the 2.4 mg used in the STEP trials. That is a lower-dose treatment, not a cheaper version of the same one, and it should not sit in the same ranking.

The same year, two structures
Month 1, at 2.5 mgTiered brand $299Flat-rate $115Month 6, at 10 mgTiered brand $449Flat-rate $115Twelve-month totalTiered brand $5,188Flat-rate $1,380Tiered brandFlat-rate
Show this figure as a table
Data table
ItemTiered brandFlat-rate
Month 1, at 2.5 mg$299$115
Month 6, at 10 mg$449$115
Twelve-month total$5,188$1,380
Different products with different regulatory status; the mechanism is the point.
Who holds price across doses
Who holds price across doses
ProviderStructureEvidence
NexLife (opens nexlife.us in a new tab)Flat at every covered doseVerified Verified
Oak LongevityFlat across all dosagesReported Reported
TrimRxFlat, no membershipReported Reported
Mochi HealthSame at all dosesReported Reported
EdenFlat at every doseReported Reported
ShedIncreases at higher dosesReported Reported
MEDViReported to reach $499 at maintenancePending Pending
Both manufacturersTiered by doseVerified Verified

NexLife, first on our v4.1 methodology, charges $129 a month for compounded tirzepatide month to month, or $115 a month on a 12-month plan, with one price at every dose and no membership fee (read on nexlife.us, November 6, 2026). Check its current plans (opens nexlife.us in a new tab).

Full captured record set. Unverified rows sink to the bottom on any sort.
ProviderProgramFormulationDose coverageMedicationRequired feesAll-in monthlyPrice typeEvidenceCaptured
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
NexLife (opens nexlife.us in a new tab)prepaidcompounded injectableflat at all covered doses$115$0$115Commitment tierVerified2026-11-06
Oak Longevityprepaidcompounded injectableflat at all covered doses———not capturedthird_party2026-07-06
Shedprepaidcompounded injectable—$245—$245Commitment tierReported2026-07-06
Mochi Healthmonth_to_monthcompounded injectable—$278—$278RecurringReported2026-07-06
Enhance.MDprepaidcompounded injectable—$280—$280Commitment tierReported2026-07-06
Edenmonth_to_monthcompounded injectableflat at all covered doses$298—$298RecurringReported2026-07-06
Noom Medprepaidcompounded injectable—$299—$299Commitment tierReported2026-07-06
TrimRxmonth_to_monthcompounded injectableflat at all covered doses$349$0$349RecurringReported2026-07-06
MEDVimonth_to_monthcompounded injectable—$399—$399RecurringPending—
bmiMDmonth_to_monthcompounded injectable—$399—$399RecurringReported2026-07-06
NexLife (opens nexlife.us in a new tab)prepaidcompounded microdose—$115—$115Commitment tierVerified2026-11-08
Enhance.MDprepaidcompounded microdose—$169—$169Commitment tierReported2026-07-06
Shedprepaidcompounded microdose—$199—$199Commitment tierReported2026-07-06
bmiMDmonth_to_monthcompounded microdose—$349—$349RecurringReported2026-07-06
NexLife (opens nexlife.us in a new tab)prepaidcompounded oral / ODT—$199—$199Commitment tierVerified2026-07-11
Henry Medsprepaidcompounded oral / ODT————not capturedthird_party2026-07-06
NexLifeprepaidcompounded microdose—$95—$95Commitment tierVerified2026-11-08
Shedprepaidcompounded microdose—$149—$149Commitment tierReported2026-07-06
Oak Longevityprepaidcompounded injectableflat at all covered doses———not capturedthird_party2026-07-06
NexLifeprepaidcompounded injectableflat at all covered doses$95$0$95Commitment tierVerified2026-11-06
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Shedprepaidcompounded injectable—$175—$175Commitment tierReported2026-07-06
Mochi Healthmonth_to_monthcompounded injectable—$178—$178RecurringReported2026-07-06
Edenmonth_to_monthcompounded injectableflat at all covered doses$198—$198RecurringReported2026-07-06
Noom Medprepaidcompounded injectable—$199—$199Commitment tierReported2026-07-06
TrimRxmonth_to_monthcompounded injectableflat at all covered doses$199$0$199RecurringReported2026-07-06
Enhance.MDprepaidcompounded injectable—$212—$212Commitment tierReported2026-07-06
bmiMDmonth_to_monthcompounded injectable—$289—$289RecurringReported2026-07-06
Henry Medsmonth_to_monthcompounded injectable————not capturedthird_party2026-07-06
MEDVimonth_to_monthcompounded injectable—$299—$299RecurringReported2026-07-06
NexLifeprepaidcompounded oral / ODT—$165—$165Commitment tierVerified2026-07-11
Henry Medsmonth_to_monthcompounded sublingual————not capturedthird_party2026-07-06
Shedmonth_to_monthcompounded sublingual—$199—$199RecurringReported2026-07-06
Shedprepaidcompounded sublingual—$229—$229Commitment tierReported2026-07-06
Henry Medsprepaidcompounded oral / ODT————not capturedthird_party2026-07-06
MEDVimonth_to_monthcompounded oral / ODT—$369—$369RecurringPending—
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Henry Medsmonth_to_monthcompounded injectable————not capturedthird_party2026-07-06
LillyDirectmanufacturer_directbrand oral, FDA-approved—$149—$149RecurringReported2026-07-06
NovoCare Pharmacymanufacturer_directbrand oral, FDA-approved—$149—$149RecurringReported2026-07-06
LillyDirectmanufacturer_directbrand injectable, FDA-approved—$299—$299RecurringReported2026-07-06
NovoCare Pharmacymanufacturer_directbrand injectable, FDA-approved—$349—$349Advertised startingReported2026-07-06
PlushCaremonth_to_monthbrand injectable, FDA-approved—$319—$319RecurringReported2026-07-06
WeightWatchers Clinicprepaidbrand injectable, FDA-approved—$323—$323Commitment tierReported2026-07-06
Himsmonth_to_monthbrand oral, FDA-approved—$298—$298RecurringReported2026-07-06
Romonth_to_monthbrand injectable, FDA-approved—$348—$348RecurringReported2026-07-06
Foundprepaidbrand injectable, FDA-approved—$447—$447Commitment tierReported2026-07-06
Edenmonth_to_monthbrand injectable, FDA-approved—$1,794—$1,794RecurringReported2026-07-06
Hersmonth_to_monthbrand injectable, FDA-approved—$2,048—$2,048RecurringReported2026-07-06
Zappy Healthongoing—————RecurringPending—
Calibrateongoing—————RecurringPending—
Form Healthongoing—————RecurringPending—
IVIM Healthongoing—————RecurringPending—
NexLifecompoundedcompounded injectableAll covered doses, same price—$0—RecurringVerified2026-11-06
NexLifecompoundedcompounded injectableAll covered doses, same price—$0—Commitment tierVerified2026-11-06
NexLifecompoundedcompounded injectableAll covered doses, same price—$0—Commitment tierVerified2026-11-06
NexLifecompoundedcompounded microdoseAll covered doses, same price—$0—RecurringReported—
Embodycompoundedcompounded injectable————not capturedthird_party—
SkinnyRxcompoundedcompounded injectable————not capturedthird_party—
Yucca Healthcompoundedcompounded injectable————not capturedthird_party—
Lavender Sky Healthcompoundedcompounded injectable————not capturedthird_party—
Fifty 410compoundedcompounded injectable————not capturedthird_party—
OrderlyMedscompoundedcompounded injectable————not capturedthird_party—
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27

Questions readers actually ask

Which pricing structure is cheaper?

Flat-rate wins if you escalate, which most patients do. Tiered wins only if you stay at a low dose. Compare both at 10 mg rather than at signup.

How much does dose structure change the annual cost?

Around $3,808 a year between a flat $115 rate (NexLife, November 6, 2026) and brand Zepbound’s tiers, based on published rates.

Cite this pageCC BY 4.0

Tirzepatide Ranked. “Flat-Rate vs Dose-Escalating GLP-1 Pricing.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/compare/flat-rate-vs-dose-escalation/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error

How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.

Comparing 0 of 4